Photo for representational purpose only
New Delhi, July 24
Brazil on Saturday suspended clinical trials of Bharat Biotech’s Covid-19 vaccine candidate Covaxin after the Indian company yesterday terminated the contract with its Brazilian partner. Brazil’s health regulator Anvisa announced the suspension of trials after Bharat Biotech on Friday said it had cancelled the MoU with Precisa Medicamentos and Envixia Pharmaceuticals for the supply of 20 million doses of Covaxin doses to the South American nation.
“The suspension was carried out as a result of a statement from the Indian company Bharat Biotech International, sent to Anvisa on
Friday,” said the Brazilian health regulator today, close on the heels of the $320 million deal to buy Covaxin landing into controversy in Brazil, ultimately leading to Bharat Biotech cancelling its MoU with the partners that were embroiled in a scandal there.
Brazil had on July 30 suspended the multi-million dollar deal with Biotech on the recommendations of the federal comptroller general. — TNS
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Swati Maliwal goes to Tiz Hazari court to record statement before magistrate; police expected to reach Arvind Kejriwal’s house to probe assault case
Delhi BJP Mahila Morcha members protest near Kejriwal's resi...
Ghatkopar hoarding collapse accused brought to Mumbai, to be produced in court today
Was apprehended from Udaipur in Rajasthan on Thursday
Delhi-bound Air India flight from Pune collides with tug truck before takeoff
Emergency protocols are swiftly enacted, ensuring the safety...
India’s economy to expand by around 7 per cent this year, country getting more investments than China: UN
The mid-year update of the World Economic Situation and Pros...
